Pharmalot... Pharmalittle... Good Morning

Top of the morning to you. Another bright, shiny day is unfolding here on the chilly Pharmalot corporate campus, where the falling leaves are blanketing the grounds and we are trying to keep warm with a cup of stimulation. As always, a busy day lies ahead and we trust that you can relate. So, time to get cracking, as they say. After all, it is only the middle of the week. So here are a few items of interest. Hope you day goes well and do stay in touch... FDA Panel Backs Biomarin Rare Disease Drug (Bloomberg News) Amgen Cholesterol Drug Appears Safe And Effective: Study (Reuters) Google's Calico Adds Roche Exec As R&D Head (BioCentury) Roche Wins EU Backing To Market Kadlyca For Breast Cancer (PM Live) Former Teva CEO Levin: "I'm An Unemployed Immigrant" (Globes) Daiichi Bloodthinner Succeeds In Major Study (Reuters) EMA Expands Pact With European Cost Watchdog (Pharma Times) EDITOR'S NOTE: Please check this post for additional stories during the day Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs